Latest Developments in Global Wearable Biosensors In Clinical Trials Market

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Latest Developments in Global Wearable Biosensors In Clinical Trials Market

  • Healthcare
  • Upcoming Report
  • Dec 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • In October 2024, Strados Labs has partnered with Trialogics, a clinical trial software and logistics provider, to enhance the distribution of its RESP Biosensors to clinical trial sites worldwide. This collaboration will help Strados Labs optimize logistics, improving the efficiency and reach of their product in global clinical trials
  • In April 2024, according to an article published by smartQare, Royal Philips has partnered with smartQare to integrate its viQtor solution with Philips' clinical patient monitoring platforms, starting in Europe. This collaboration will help Philips enhance its continuous patient monitoring capabilities, both in and outside of hospitals, expanding its reach and improving patient care

Frequently Asked Questions

The market is segmented based on Global Wearable Biosensors in Clinical Trials Market Segmentation, By Product Type (Biosensor Patches, Wearable Devices, Smart Clothing, and Implantable Biosensors), Sensor Type (Electrochemical Sensors, Optical Sensors, Piezoelectric Sensors, Temperature Sensors, and Biochemical Sensors), Application (Chronic Disease Management, Clinical Trials Monitoring, Fitness and Wellness Monitoring, Real-Time Health Monitoring, and Emergency Care), End-User (Pharmaceutical Companies, Biotech Companies, Contract Research Organizations (CROs), and Hospitals and Clinical Centers), Distribution Channel (Direct Sales, Online Sales, and Third-Party Distributors) – Industry Trends and Forecast to 2032 .
The Global Wearable Biosensors In Clinical Trials Market size was valued at USD 384.24 USD Million in 2024.
The Global Wearable Biosensors In Clinical Trials Market is projected to grow at a CAGR of 11% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.